Skip to content
healthcare.dev

Nucala

NDC 0173-0881, mepolizumab, injection, powder, for solution, from GlaxoSmithKline LLC.

Product NDC
0173-0881
Status
Listed
Labeler
GlaxoSmithKline LLC
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125526
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0881 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEPOLIZUMAB100 mg/mL

Pharmacologic classes

Interleukin-5 Antagonist [EPC]; Interleukin-5 Antagonists [MoA]

Package NDCNDC-11Package
0173-0881-01001730881011 VIAL in 1 CARTON (0173-0881-01) / 1 mL in 1 VIAL
0173-0881-61001730881611 VIAL in 1 CARTON (0173-0881-61) / 1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fefb887c-e4ac-431e-8893-e9d1a5a63fea
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0173-0881

Use it

Look up 0173-0881 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0881 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0173-0881. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.